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ABSTRACT 
Introduction  
Drug-related problems are frequent and may result in reduced quality of life, and even morbidity and mortality. 
Studies have shown that clinical pharmacists can identify and prevent drug-related problems. Although the 
physicians in Pakistan like some underdeveloped countries seem to have an opposing view to the expanded role 
of clinical pharmacists.  
Method 
$ VXUYH\ ZDV FRQGXFWHG LQ ZKLFK DVVHVVHG SK\VLFLDQ¶V LQWHUDFWLRQ H[SHULHQFH DQG H[SHFWDWLRQV IURP D
pharmacist especially in a patient-oriented role.  
Results 
The findings reveal limited interactions; those limited interactions included inquiring information about 
particular drug availability only. About 80 to 90% of physicians have high expectations of pharmacists 
indicating that they should be solely responsible for any medication related query and should be equipped with 
extensive knowledge to tackle drug related problems effectively, however a higher % seem to disagree on 
DOORZLQJ D FOLQLFDO SKDUPDFLVW¶V LQWHUYHQWLRQ ZLWKLQ D SDWLHQW SURILOH WKH SK\VLFLDQV ZLWK OHVV WKDQ  \HDUV
experience disagree on allowing them to be involved on the level of consultation regarding drug regimens or 
other and work side by side with them as core members of healthcare team.  
Conclusion 
These mixed reviews indicate the lack of comfort of physicians in a clinical setting. There is increasing evidence 
that participation and interventions of clinical pharmacists in health care positively influence clinical practice 
yet the state of non recognition of clinical role of pharmacists in Pakistan still needs to be addressed in order to 
win over SK\VLFLDQFRQILGHQFHDQGFRPIRUWDQGFDQOHDGWREHWWHURXWFRPHVRISDWLHQW¶VKHDOWKDQGFRQVHTXHQWO\
improvement in the health care system of the country.  
Keywords:Perception; Experience; Physician; Clinical Pharmacist; Karachi; Pakistan 
 
INTRODUCTION 
The legitimacy of expanded roles for pharmacists 
with different status audiences has been studied in 
many parts of the world, defining pharmacy as a 
profession in transition characterized by 
considerable ambiguity and uncertainty concerning 
its status as a health care profession. Significant 
changes have occurred within the profession of 
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pharmacy in the past few decades which have led 
to loss of function, social power and status. The 
response of the profession has been a movement 
toward a patient-oriented, clinical role for 
pharmacists.[1] 
Hypotheses concerning level of support for 
expanded roles of healthcare professionals were 
derived from two conflict-based models of 
professionalization: (1) a power model which 
focuses on conflict between professions and the 
central role of power in defining occupational 
territory; and (2) a process model which focuses on 
conflict of interest and diversity within a profession 
DQG WKHGHYHORSPHQWRI µVHJPHQWV¶ZKLFKVWUXJJOH
for control of a profession's direction. [1] If these 
conflict based models did not exist, the expanded 
roles of different health care professions can be 
given the required support, given that the 
prescribing is optimal for the individual patient i.e. 
one of role of a physician, efforts should be made 
to enhance adherence to medications, one of many 
roles of a clinical pharmacist.[1, 2] 
Clinical pharmacists are uniquely trained in 
therapeutics and provide comprehensive drug 
management to patients and providers (includes 
physicians and additional members of the care 
team). Pharmacist intervention outcomes include 
economics, health-related quality of life, patient 
satisfaction, medication appropriateness, adverse 
drug events (ADEs), and adverse drug reactions 
(ADRs). A cornerstone of clinical pharmacy is the 
identification, solving and prevention of drug-
related problems. A clinical pharmacist may assess 
these drug-related problems in different settings: in 
hospital multidisciplinary teams, in nursing homes 
and in primary care.[3, 12] 
In Pakistan, the profession lacks government 
interest, causing clinical and hospital pharmacists 
to still struggle for the recognition of their 
professional influence in the healthcare system of 
Pakistan and face many great barriers to fully 
execute their potential role irrespective to the 
amount of human resource in the country, as almost 
two and half thousand pharmacists graduate every 
year. Several reasons for the lack of recognition are 
defined, one of them includes lack of physician-
pharmacist interaction at a hospital setting.[11] Due 
to lack of interaction and knowledge regarding the 
role of pharmacist in a clinical setting it is still an 
emerging trend in Pakistan and face the same 
situation as other developing countries. Physicians 
in Pakistan are still unsure about the prospect of the 
inclusion of pharmacist in the clinical and 
counseling role.[5] 
Various studies emphasize that interventions by 
clinical pharmacists improve clinical outcomes, 
such as improvement in levels of markers for drug 
use and disease, for example, more optimal lipid 
levels and INR levels, reduced length of hospital 
stay, fewer re-admissions and fewer disease events 
for e.g. heart failure events or thromboembolism. [8, 
10]
 A proactive rather than a reactive approach 
seems prudent for obtaining the greatest benefit 
from the interventions. This includes pharmacist 
participation in the multidisciplinary team 
discussions ± at the stage of ordering and 
prescribing ± where all types of drug-related 
problems, including potential problems, are 
undertaken professional responsibility. There is 
increasing evidence that participation and 
intervention of clinical pharmacists have a positive 
influence on clinical outcomes and can contribute 
to overall improvement of healthcare.[9,10] Although 
the exact views and perceptions of Pakistani 
physicians for this discipline of pharmacy in 
particular needs to defined, especially in the light 
of the conflict of interest and diversity among these 
professions keeping in view the level of support 
regarding team work needed in the health sector of 
Pakistan.[8,11, 13]  
 
MATERIALS AND METHODS 
A quantitative cross sectional study was conducted 
among the physicians of Karachi, Pakistan during 
the time period of March 2013 to December 2013. 
The target population were the physicians, targeted 
with a structured questionnaire which was divided 
into the following parts i.e., demographic 
information of the physicians, and interactions, 
expectations and experiences with pharmacist.  
Prior to the data collection, an approval from health 
care facility and informed, written consent from 
respondents was obtained. The first part of the 
TXHVWLRQQDLUH DVVHVVHG WKH OHYHO RI SK\VLFLDQ¶V
interaction and reasons for interaction with 
pharmacist; the second part assessed their 
expectations with pharmacists; whereas the last 
part assessed their experiences with pharmacists.  
In expectations and experiences section, the 
physicians had to respond using the 4 point Likert 
scale hence 1= strongly agree, 2= agree, 3= 
disagree and 4= strongly disagree. This lower case 
Scale was used to avoid confusion of neutral 
opinion.  
The survey was limited to physicians from Karachi 
practicing in different areas which include private, 
public sector, general and specialized hospitals.  A 
sample size of (N = 300) physicians was selected to 
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take part in the survey by questionnaire 
distribution, out of them 278 returned the complete 
filled questionnaires. 
The data were computed and analyzed using 
Statistical Package for Social Sciences (SPSS 
version 22) and descriptive analysis was conducted. 
The results of each item in the questionnaire were 
reported as percentage (%) and sample number (N). 
The Chi±square test (X2) was used to test the 
importance of association between the independent 
demographic variables (gender, experience of 
practice, specialty, and status) and the dependent 
YDULDEOHV SK\VLFLDQ¶V IUHTXHQF\ RI LQWHUDFWLRQ
expectations and experience with the pharmacist). 
Statistical significance was accepted at P value of  
< 0.05.  
 
RESULTS 
A total of 300 questionnaires were sent to the 
physicians in hospitals of Karachi, Pakistan out of 
which 278 questionnaires were filled and returned 
giving a response rate of 92.6%. The results are 
expressed in the following sections: 
¾ Demographic information 
¾ Social information 
¾ Personal Experiences 
 
Demographic information 
The survey incorporated almost an equal number of 
physicians in terms of gender i.e. males (N = 121, 
43.5%) and females (N = 157, 56.5%) as well as 
place of work i.e. general hospital (N = 142, 
51.1%) and specialized hospitals (N = 136, 48.9%). 
In addition, with regards to the position in 
organization, the survey incorporated equal number 
of GPs and Residents i.e. (N = 97, 34.9%) and a 
third were the consultants (N = 84, 30.2%). Almost 
a half of the physicians (N = 157, 56.5%) worked 
at private institutes and slightly less than half in a 
public health care institute (N = 121, 43.5%). 
Majority of physicians (N = 131, 47.1%) had a 
relevant work experience of less than 5 years, a 
third (N = 92, 33.1%) had an experience between 
5-10 years, some (N = 36, 12.9%) had experience 
greater than 10 years and few (N = 19, 6.8%) had 
greater than 50 years of relevant work experience.  
Furthermore, almost a half of the physicians (N = 
141, 50.7%) rarely or never interacted with a 
clinical pharmacist a quarter (N = 69, 24.8%) did 
however interact with a clinical pharmacist once a 
week and almost similar number of physicians (N = 
68, 24.5%) interacted once daily. The demographic 
information is tabulated in table 1. 
Table 1 Demographic information of physicians 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Frequency of Interaction 
never/ rarely 
once a week 
once daily 
 
141 (50.7) 
69 (24.8) 
68 (24.5) 
Variable Sample N (%) 
Gender 
Male 
Female 
 
121 (43.5) 
157 (56.5) 
Place of work 
General Hospital 
Specialized Hospital 
 
142 (51.1) 
136 (48.9) 
Current position 
Consultant 
Resident 
GP 
 
84 (30.2) 
97 (34.9) 
97 (34.9) 
Type of health care institute 
Private 
Public 
 
 
157 (56.5) 
121 (43.5) 
Years of experience 
<5 years 
5-10 years 
> 10 years 
> 50 years 
 
131 (47.1) 
92 (33.1) 
36 (12.9) 
19 (6.8) 
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Furthermore, with regards to the qualitative 
aspects, the reasons for interaction normally given 
by physicians mainly were concerned with the dose 
related queries (N = 43, 15.5%) followed by 
pharmaceutical alternative queries (N = 32, 11.5%). 
Few other reasons for interactions are given in 
table 2. 
 
Table 2 Reasons for interaction 
Reason for interaction Sample N (%) 
Drug availability queries 21 (7.6) 
 
Drug alternative queries 24 (8.6) 
 Drug dosage queries 43 (15.5) 
 
Side effects queries 13 (4.7) 
 
Drug interaction queries 12 (4.3) 
 
Drug Availability queries / Drug alternative queries 32 (11.5) 
Drug availability queries / Drug dosage queries 13 (4.7) 
Drug availability queries / Side Effects queries 2 (0.7) 
Drug availability queries / Drug interaction queries 7 (2.5) 
Drug alternative queries / Drug dosage queries 4 (1.4) 
Drug alternative queries / Side effects queries 8 (2.9) 
Drug alternative queries / Drug interaction queries 2 (0.7) 
Drug dosage queries / Side effects queries 1 (0.4) 
Drug dosage queries / Drug interaction queries 10 (3.6) 
Side effect queries / Drug interaction queries 4 (1.4) 
Drug availability queries / Drug alternative queries / Drug dosage queries 6 (2.2) 
Drug availability queries / Drug dosage queries / Side effects queries 6 (2.2) 
Drug availability queries / Side effects queries / Drug interaction queries 2 (0.7) 
Drug alternative queries / Drug dosage queries / Side effects queries 8 (2.9) 
Drug alternative queries / Side effects queries / Drug interaction queries 9 (3.2) 
Drug dosage queries / side effects queries / Drug interaction queries 11 (4.0) 
Drug dosage queries / Drug interaction queries / Drug availability queries 7(2.5) 
Drug dosage queries / Drug interaction queries / Drug alternative queries 4 (1.4) 
Drug Availability queries / Drug alternative queries / Side effects queries 8 (2.9) 
Drug Availability queries / Drug alternative queries / Drug interaction queries 21(7.6) 
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Social information 
The social aspects of the study revealed that the 
demographics influenced the perceptions of the 
physicians. The demographics such as the 
designation, working experience and organization 
influenced their expectations from clinical 
pharmacists. The study investigated the 
associations of the health care institute of 
physicians and their expectations from a clinical 
pharmacist. Social variables pertaining to clinical 
pharmacists were asked about. Table 3 provides a 
detailed account. 
 
Table 3 Health care institute of physicians affecting their expectation from a clinical pharmacist 
 
S.No Variable Institute Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
P-value 
1. To take personal responsibility 
for resolving any drug-related 
problems 
Private 30 (19.1) 91 (58) 26 (16.6) 10 (6.4) 0.00 
Public 13 (10.7) 49 (40.5) 27 (22.3) 32 (26.4) 
2. To be knowledgeable drug 
therapy expert 
Private 77 (49) 77 (49) 1 (.6) 2 (1.3) 0.00 
Public 17 (14) 100 
(82.6) 
4 (3.3) 0 (0) 
3. To assist me in designing drug 
therapy treatment plans for my 
patients 
Private 38 (24.2) 60 (38.2) 54 (34.4) 5 (3.2) 0.00 
Public 16 (13.2) 96 (34.5) 104 (37.4) 24 (8.6) 
4. 7RPRQLWRUP\SDWLHQWV¶
response to drug therapy 
 
Private 35 (22.3) 111 
(70.7) 
11 (7.0) 0 (0) 0.00 
Public 8 (6.6) 86 ( 1.1) 25 (20.7) 2 (.9) 
5. Educate patient about save use 
of medication 
Private 55 (35) 91 (58) 11 (7) 0 (0) 0.008 
Public 22 (18.2) 89 (73.6) 10 (8.3) 0 (0) 
6. To know the specific indication 
of each drug I prescribe. 
 
Private 30 (19.1) 90 (57.3) 29 (18.5) 8 (5.1) 0.001 
Public 17 (14) 94 (77.7) 10 (8.3) 0 (0) 
7. To be available to me for 
consultation when I see 
patients (e.g. During rounds) 
Private 14 (8.9) 68 (43.3) 59 (37.6) 16 (10.2) 0.00 
Public 19 (15.7) 20 (16.5) 56 (46.3) 26 (21.5) 
8. To assist my patients in 
selecting appropriate non-
prescription medications 
Private 38 (24.2) 47 (29.9) 36 (22.9) 36 (22.9) 0.40 
Public 16 (13.2) 30 (24.8) 39 (32.2) 36 (29.8) 
 
 
With respect to the position in the health care 
institute, it was formulated as a demographic v 
 
ariable which was tested for association with their 
expectations from a clinical pharmacist. Table 4 
provides a detailed account. 
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Table 4 Position of physicians affecting their expectation from clinical pharmacists 
 
S.No Variable Designation Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
P-
value 
1. To take personal responsibility 
for resolving any drug-related 
problems 
Consultant 10 (11.9) 25 (29.8) 16 (19) 33 (39.3) 0.00 
Resident 11 (11.3) 64 (66) 16 (18.5) 6 (6.2) 
GP 22 (22.7) 51 (52.6) 21 (21.6) 3 (3.1) 
2. To be knowledgeable drug 
therapy expert 
Consultant 14 (16.7) 70 (83.3) 0 (0) 0 (0) 0.00 
Resident 54 (55.7) 40 (41.2) 1 (1) 2 (2.1) 
GP 26 (26.8) 67 (69.1) 4 (4.1) 0 (0) 
3. To assist me in designing drug 
therapy treatment plans for my 
patients 
Consultant 8 (9.5) 36 (42.9) 26 (31) 14 (16.7) 0.00 
Resident 32 (33) 19 (19.6) 40 (41.2) 6 (6.2) 
GP 14 (14.4) 41 (42.3) 38 (39.2) 4 (4.1) 
4. 7RPRQLWRUP\SDWLHQWV¶
response to drug therapy 
 
Consultant 9 (10.7) 71 (84.5) 4 (4.8) 0 (0) 0.00 
Resident 28 (28.9) 65 (67) 4 (4.1) 0 (0) 
GP 6 (6.2) 61 (62.9) 28 (28.9) 2 (2.1) 
5. Educate patient about save use 
of medication 
Consultant 9 (10.7) 73 (86.9) 2 (2.4) 0 (0) 0.00 
Resident 46 (47.4) 49 (50.5) 2 (2.1) 0 (0) 
GP 22 (22.7) 58 (59.8) 17 (17.5) 0 (0) 
6. To know the specific 
indication of each drug I 
prescribe. 
 
Consultant 24 (28.6) 53 (63.1) 7 (8.3) 0 (0) 0.01 
Resident 10 (10.3) 66 (68) 17 (17.5) 4 (4.1) 
GP 13 (13.4) 65 (67) 15 (15.5) 4 (4.1) 
7. To be available to me for 
consultation when i see 
patients (e.g. During rounds) 
Consultant 10 (11.9) 14 (16.7) 35 (41.7) 25 (29.8) 0.00 
Resident 2 (2.1) 56 (57.7) 29 (29.9) 10 (10.3) 
GP 21 (21.6) 18 (18.6) 51 (52.6) 7 (7.2) 
8. To assist my patients in 
selecting appropriate non-
prescription medications 
Consultant 14 (16.7) 12 (14.3) 18 (21.4) 40 (47.6) 0.00 
Resident 20 (20.6) 47 (48.5) 13 (13.4) 17 (17.5) 
GP 20 (20.6) 18 (18.6) 44 (45.4) 15 (15.5) 
 
Personal experiences 
Furthermore, the study investigated the 
associations of relevant work experience of  
 
 
physicians and their expectations from a clinical 
pharmacist. Table 5 provides a detailed account. 
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Table 5 Experiences of physicians affecting their expectation from clinical pharmacists 
 
S.No Variable Experience Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
P-
value 
1. To take personal responsibility 
for resolving any drug-related 
problems 
< 5 30 (17.9) 81 (48.2) 36 (21.4) 21 (12.5) 0.165 
5-10 11 (15.3) 40 (55.6) 10 (13.9) 11 (15.3) 
>10 2 (5.3) 19 (50) 7 (18.4) 10 (26.3) 
2. To be knowledgeable drug 
therapy expert 
< 5 54 (32.1) 108 (64.3) 4 (2.4) 2 (1.2) 0.002 
5-10 36 (50) 35 (45.8) 1 (1.4) 0 (0) 
>10 4 (10.5) 34 (89.5) 0 (0) 2 (0.7) 
3. To assist me in designing drug 
therapy treatment plans for my 
patients 
< 5 36 (21.4) 58 (34.5) 57 (33.9) 17 (10.1) 0.002 
5-10 16 (22.2) 15 (20.8) 36 (50) 5 (6.9) 
>10 2  (5.3) 23 (60.5) 11 (28.9) 2(5.3) 
4. 7RPRQLWRUP\SDWLHQWV¶
response to drug therapy 
 
< 5 24 (14.3) 112 (66.7) 30 (17.9) 2 (1.2) 0.025 
5-10 10 (13.9) 60 (83.3) 2 (2.8) 0 (0) 
>10 9 (23.7) 25 (65.8) 4 (10.5) 0 (0) 
5. Educate patient about save use 
of medication 
< 5 44 (26.2) 109 (64.9) 
 
15 (8.9) 0 (0) 0.243 
5-10 26 (36.1) 42 (58.3) 4 (5.4) 0 (0) 
>10 7 (18.4) 29 (76.3) 2 (5.3) 0 (0) 
6. To know the specific 
indication of each drug i 
prescribe. 
 
< 5 17 (10.1) 118 (70.2) 25 (14.9) 8 (4.8) 0.006 
5-10 20 (27.8) 43 (59.7) 9 (12.5) 0 (0) 
>10 10 (26.3) 23 (60.5) 5 (13.2) 0 (0) 
7. To be available to me for 
consultation when i see 
patients (e.g. During rounds) 
< 5 25 (14.9) 44 (26.2) 74 (44) 25 (14.9) 0.000 
5-10 4 (5.6) 38 (52.8) 19 (26.4) 11 (15.3) 
>10 4 (10.5) 6 (15.8) 22 (57.9) 6 (15.8) 
8. To assist my patients in 
selecting appropriate non-
prescription medications 
< 5 36 (21.4) 44 (26.2) 53 (31.5) 35 (20.8) 0.00 
5-10 10 (13.9) 31 (43.1) 9 (12.5) 22 (30.6) 
>10 8 (21.1) 2 (5.3) 13 (34.2) 15 (39.5) 
 
In addition, the study investigated the associations 
of the health care institute of physicians and their 
personal experience from a clinical pharmacist. 
Table 6 provides a detailed account. 
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Table 6 Health care institute of physicians affecting their personal experience from clinical pharmacists 
 
S.No Variable Institute Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
P-
value 1. Pharmacists are a reliable source of 
general drug information 
Private 48 (30.6) 97 (61.8) 9 (5.7) 3 (1.9) 0.014 
Public 22 (18.2) 77 (63.6) 18 (14.9) 4 (3.3) 
2 Pharmacists are a reliable source of 
clinical drug information 
Private 28 (17.8) 108 (68.8) 19 (12.1) 2 (1.3) 0.034 
Public 21 (17.4) 68 (56.2) 26 (21.5) 6 (5.0) 
3. Pharmacists routinely counsel my 
patients regarding the safe and 
appropriate use of their 
Private 10 (6.4) 77 (49) 68 (43.3) 2 (1.3) 0.00 
Public 2 (1.7) 69 (57) 37 (30.6) 13 (10.7) 
4. Pharmacists routinely inform me if 
they discover clinical problems 
ZLWKP\SUHVFULSWLRQV¶ 
 
Private 38 (24.2) 85 (54.1) 34 (21.7) 0 (0) 0.00 
Public 20 (16.5) 57 (47.1) 27 (22.3) 17 (14) 
5. Pharmacists routinely inform me 
about more cost-effective 
alternatives to the drugs 
Private 10 (6.4) 67 (42.7) 77 (72.3) 3 (1.9) 0.00 
Public 14 (11.6) 37 (30.6) 51 (42.1) 19 (15.7) 
6. Pharmacists frequently ask me to 
clarify for them the drug therapy 
objectives. 
 
Private 2 (1.3) 58 (36.9) 94 (59.9) 3 (1.9) 0.00 
Public 4 (3.3) 80 (66.1) 22 (18.2) 15 (12.4) 
7. Pharmacists appear willing to take 
personal responsibility for 
resolving any drug-related 
problems they discover 
Private 11.9 (4.5) 83 (52.9) 56 (35.7) 11 (7.0) 0.00 
Public 14 (11.6) 32 (26.4) 47 (38.8) 28 (23.1) 
8. I am willing to in-corporate the 
pharmacotherapy for the patient 
with consultation of the pharmacist 
Private 6 (3.8) 119 (75.8) 20 (12.7) 12 (7.6) 0.00 
Public 17 (14) 57 (47.1) 20 (16.5) 27 (22.3) 
 
 
Moreover, the study investigated the associations 
of the designations of physicians affecting their 
personal experiences from a clinical pharmacist. 
Table 7 provides a detailed account
. 
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Table 7 Position of physician affecting the experience with clinical pharmacists 
 
S.No Variable Designation Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
P-
value 
1. Pharmacists are a reliable source 
of general drug information 
Consultant 12 (14.3) 63 (75) 9 (10.7) 0 (0) 0.00 
Resident 38 (39.2) 57 (58.8) 2 (2.1) 0 (0) 
GP 20 (20.6) 54 (55.7) 16 (!6.5) 7 (7.2) 
2. Pharmacists are a reliable source 
of clinical drug information 
Consultant 16 (19) 45 (53.6) 23 (27.4) 0 (0) 0.00 
Resident 10 (10.3) 77 (79.4) 10 (10.3) 0 (0) 
GP 23 (23.7) 54 (55.7) 12 (12.4) 8 (8.2) 
3. Pharmacists routinely counsel 
my patients regarding the safe 
and appropriate use of their 
medications 
Consultant 4 (4.8) 44 (52.4) 29 (34.5) 7 (8.3) 0.83 
Resident 2 (2.1) 54 (55.7) 41 (42.3) 0 (0) 
GP 6 (6.2) 48 (49.5) 35 (36.1) 8 (8.2) 
4. Pharmacists routinely inform 
me if they discover clinical 
SUREOHPVZLWKP\SUHVFULSWLRQV¶ 
Consultant 12 (14.3) 48 )57.1) 15 (17.9) 9 (10.7) 0.00 
Resident 28 (28.9) 55 (56.7) 14 (14.4) 0 (0) 
GP 18 (18.6) 39 (40.2) 32 (33) 8 (8.2) 
5. Pharmacists routinely inform 
me about more cost-effective 
alternatives to the drugs 
 
Consultant 8 (9.5) 20 (23.8) 46 (54.8) 10 (11.9) 0.00 
Resident 0 (0) 46 (47.4) 51 (52.6 0 (0) 
GP 16 (16.5) 38 (39.2) 31 (32) 12 (7.9) 
6. Pharmacists frequently ask me 
to clarify for them the drug 
therapy objectives. 
Consultant 2 (2.4) 42 (50) 31 (36.9) 9 (10.7) 0.00 
Resident 0 (0) 35 (36.1) 60 (61.9) 2 (2.1) 
GP 4 (4.1) 61 (62.9) 25 (25.8) 7 (7.2) 
7. Pharmacists appear willing to 
take personal responsibility for 
resolving any drug-related 
problems they discover 
Consultant 4 (4.8) 28 (33.3) 23 (27.4) 29 (34.5) 0.00 
Resident 0 (0) 62 (63.9) 31 (32) 4 (4.1) 
GP 17 (17.5) 25 (25.8) 49 (50.5) 6 (6.2) 
8. I am willing to in-corporate the 
pharmacotherapy for the patient 
with consultation of the 
pharmacist 
Consultant 2 (2.4) 47 (56) 12 (14.3) 23 (27.4) 0.00 
Resident 2 (2.1) 79 (81.4) 14 (14.4) 2 (2.1) 
GP 19 (19.6) 50 (51.5) 14 (14.4) 14 (14.4) 
 
 
Similarly, the study investigated the associations of 
the work experience of physicians and their 
account of personal experience with a clinical 
pharmacist. Table 8 provides a detailed account. 
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Table 8 Experience of physician affecting their personal experiences with a clinical pharmacist 
 
S.No Variable Experience Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
P-
value 
1. Pharmacists are a reliable source 
of general drug information 
 
< 5 54 (32.1) 93 (55.4) 14 (8.3) 7 (4.2) 0.00 
5-10 8 (11.1) 60 (83.3) 4 (5.6) 0 (0) 
>10 8 (21.1) 21 (55.3) 9 (23.7) 0 (0) 
2. Pharmacists are a reliable source 
of clinical drug information 
< 5 37 (22) 100 (59.5) 25 (14.9) 6 (3.6) 0.028 
5-10 6 (8.3) 55 (76.4) 9 (12.5) 2 (2.8) 
>10 6 (15.8) 21 (55.3) 11 (28.9) 0 (0) 
3. Pharmacists routinely counsel 
my patients regarding the safe 
and appropriate use of their 
medications 
< 5 8 (4.8) 78 (76.4) 69 (41.1) 13 (7.7) 0.072 
5-10 4 (5.6) 45 (62.5) 21 (29.2) 2 (2.8) 
>10 0 (0) 23 (60.5) 15 (39.5) 0 (0) 
4. Pharmacists routinely inform me 
if they discover clinical 
problems with my prescriSWLRQV¶ 
< 5 26 (15.5) 83 (49.4) 44 (26.9) 15 (8.9) 0.004 
5-10 24 (33.3) 38 (52.8) 8 (11.1) 2 (2.8) 
>10 8 (21.1) 21 (55.3) 9 (23.7) 0 (0) 
5. Pharmacists routinely inform me 
about more cost-effective 
alternatives to the drugs 
 
< 5 16 (9.5) 58 (34.5) 75 (44.6) 19 (11.3) 0.067 
5-10 4 (5.6) 34 (47.2) 31 (43.1) 3 (4.2) 
>10 4 (10.5) 12 (31.6) 22 (57.9) 0 (0) 
6. Pharmacists frequently ask me 
to clarify for them the drug 
therapy objectives. 
< 5 6 (3.6) 91 (54.2) 55 (32.7) 16 (9.5) 0.000 
5-10 0 (0) 22 (30.6) 48 (66.7) 2 (2.8) 
>10 0 (0) 22 (65.8) 13 (34.2) 0 (0) 
7. Pharmacists appear willing to 
take personal responsibility for 
resolving any drug-related 
problems they discover 
< 5 19 (11.3) 57 (33.9) 73 (43.5) 19 (11.3) 0.00 
5-10 0 (0) 44 (61.1) 19 (26.4) 9 (12.5) 
>10 2 (5.3) 14 (36.8) 11 (28.9) 11 (28.9) 
8. I am willing to in-corporate the 
pharmacotherapy for the patient 
with consultation of the 
pharmacist 
< 5 21 (12.5) 98 (58.3) 26 (15.5) 23 (13.7) 0.029 
5-10 0 (0) 55 (76.4) 8 (11.) 9 (12.5) 
>10 2 (5.3) 23 (60.5) 6 (15.8) 7 (18.4) 
 
DISCUSSION AND CONCLUSION 
The economic aspects of the participation of the 
clinical pharmacist in the healthcare team 
undoubtedly influenced many health care 
professions with a solution to queries associated 
with the drug and its dosage forms, regimens, 
frequency etc.[2, 3] According to the results 
extracted from this survey concerning the 
demographic aspect of physician shown in table 1 
it is found that majority of the physicians were 
under the age of 30 years out of which females 
were more in number than the males as described 
in table 2. The percentage of physicians graduated 
from private institutions was greater than from 
public sector health care institutes. Also large 
segment of the physicians that responded to the 
survey was currently practicing in general hospitals 
in which a slightly higher percentage of residents 
and general physicians were found than that of 
consultants. As the ages of the respondents less 
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than 30 years and work experience less than 5 years 
were common in the results, it can be assumed that 
this time period was adequate to experience the role 
of a clinical pharmacist within their general 
practice. 
&OLQLFDO SKDUPDFLVW¶V LQWHUDFWLRQ ZLWK SK\VLFLDQ
runs side by side in their daily practice which 
surely is a healthy tactic in order to transact the 
knowledge and eradicate adverse effects and 
certain complications regarding drugs information 
illustrated in table no 3. An infelicitous result 
obtained that says the interaction of physician and a 
clinical pharmacist take place rarely or never 
displayed in table no 2 which is quite unhealthy to 
the norm which a health system based on.[2, 4]  
This practice is commonly seen in the hospitals 
located in Karachi where physicians especially 
consultants takes a complete charge of a patient, 
neglecting the role and knowledge of pharmacist 
especially clinical pharmacist because of their so 
many years of experience which makes them a kind 
of dominant authority and on top of the food chain. 
[6-9]
 Rest of the interaction was due to drug dosage 
and availability queries from the pharmacy in 
which a physician is slightly unaware. Surprisingly, 
physicians do not interact with clinical pharmacists 
about drug-drug interaction which as a matter of 
fact is the most occurring episode above all either 
in general or specialized hospitals. Also, certain 
queries about drug alternatives, side effects are one 
of the reasons of interaction between physicians 
and pharmacists which is less in number.  From 
here one can predict that majority of the physicians 
in Karachi hospitals do not concern clinical 
pharmacists about the drug related side effects and 
drug interactions as the percentage of both these 
queries only asked by 4 to 4.5% of physicians.[10] 
Expectation from a clinical pharmacist is always 
been high from other health care professionals 
especially physician which is why the results 
illustrated in table no 4 also tells the same thing. 
91% of physician working in a private hospitals 
accept the truth that a clinical pharmacist should 
take personal responsibility for resolving any drug-
related problems out of which 52.6% are general 
physician and 66% of residents, here also the 
expectation from consultants seems to be quite low 
about 29.8%. The ratio of strongly disagree is 
highest in the public sector hospitals where mostly 
consultants denied the accountability of the clinical 
pharmacist to take this responsibility of resolving 
any drug related problems.  
The  knowledge based expectations from a clinical 
pharmacist becomes quite high, as shown in table 7 
that reveals that 82.6% of physicians from public 
hospitals wants a clinical pharmacist to be 
knowledgeable drug therapy expert, also 49% 
physician from private hospitals agree on the same 
aspect.  It is a regular and apparent job of a clinical 
pharmacist to assist the patients in selecting 
appropriate medications even if they are not from 
the prescription; this is because of they are 
equipped with knowledge about drug related 
problems. The response to this question was that 
the majority of the physicians from both public and 
private hospitals tend to disagree on this issue 
while less than half agreed. It is may be due to 
various reasons amongst which a prominent one 
seems to be related with their ownership on a 
patient profile/ case. 47.6% of consultants, 17.5 % 
of residents and 15.5 % of physicians strongly 
disagree on the same case where clinical 
pharmacist is asked to assist their patients about 
selecting the appropriate nonprescription drugs, 
this question also deviates from the survey with a 
probability value (P value = 0.40). Educating the 
patients regarding the safe and sound use of drugs 
is something physicians seems to be so conscious 
about, which is why they seemed to strongly agree 
or agree on the area where they are asked whether 
clinical pharmacists should be responsible for this 
solely or not, 86.9% of consultants agreed on this 
issue so do the 59.8% of general physicians.  
In private hospitals out of 151 physicians 91 agree 
on giving this responsibility to the clinical 
pharmacists whereas 89 physicians out of 121 in 
public sector hospitals agreed on the same thing. 
The expectation of the interaction of clinical 
pharmacists and physicians seems acceptable when 
it was found out that majority of the physician 
wants a clinical pharmacist to be available for 
consultation when they are on a clinical round, 
57.75 of residents seems to agree to this because of 
their perpetual rounds in the hospitals on each day. 
While consultants responded on the same issue to a 
very less extent (16.7% agree). This is where we 
concluded that a greater number of physicians have 
high expectations from clinical pharmacists.  
In order to know about the experience of the 
physician with the pharmacist and their drug based 
knowledge, some questions were asked revealing 
overwhelming results. The physicians were asked if 
they agree that a clinical pharmacist is a reliable 
source of general drug information or not, on which 
greater number of physicians agree (61.8% of 
private hospitals and 63.6% from public sector 
hospitals). The statistical P value came along with 
an accepting value i.e. (P value = 0.014). 
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Astonishingly, 63 out of 84 consultants agree 
UHVLGHQWVDQG*3¶V,WLVDOVRQRWHG
that these physicians were with work experience 
less than 5 years or between 5 to 10 years, and 29 
out 38 respondents agreeing were the ones with 
more than 10 year experience. 
This point is clearly noticeable that physicians are 
accepting the fact that clinical pharmacists have 
greater expertise about clinical drugs and they are 
the reliable source of clinical drug  information, 
resulting a positive response from a large number 
of physician from private hospitals (68.8%) with 
(56.2%) of public sector hospital physicians.  
An optimum era of experience is sufficient for a 
physician to realize the importance of a clinical 
pharmacists intervention as 55 out of 72 physicians 
with 5- \HDUV¶ H[SHULHQFH DJUHH WKDW SKDUPDFLVW
are the reliable source of clinical drug information. 
The point where statistics report (P value) seems to 
falter is that whether a physician would prefer a 
clinical pharmacist to routinely counsel their 
patients regarding the safe and appropriate use of 
their medications. The general practice in many 
hospitals of Karachi, Pakistan has shown that 
majority of the physicians would not prefer this 
change; whereas only some consultants and general 
physicians seem to agree. [10] 
Another part of the result reveals the exact situation 
that a pharmacist is meant to be in a hospital. 
Clinical pharmacists should routinely inform 
physicians if they discover clinical problems with 
the prescriptions. About 80% of physicians from 
private hospitals agree that allows a clinical 
pharmacist to intervene in patient medication 
profiles. 57.1% of consultants agree while 56.7% 
of residents and 40.2% of general physicians 
disagree on the respected sight. These findings also 
SRUWUD\WKDWSK\VLFLDQVKDYLQJPRUHWKDQ\HDUV¶
experience are ready for a clinical pharmacist to 
assist in the prescriptions for the errors. Pharmacist 
knows about drugs than anyone else in health care 
profession which is why they know the cost 
effective drugs having same potency and clinical 
effect.[3,11]  
The physicians were asked if they are willing that 
pharmacists routinely inform them about more 
cost-effective alternatives to the drugs. In private 
hospitals 77 out of 151 disagree while 67 agreed, 
this is because the years of experience, the chart 
showing physician with respected years of 
experience value clearly reveals that physicians 
KDYLQJ JUHDWHU WKDQ  \HDUV¶ H[SHULHQFH GLVDJUHH
while the physicians with 5- \HDUV¶ H[SHULHQFH
agree (not strongly). It can be concluded that the 
experienced chose expensive medications first in 
RUGHU WR UHIUDLQ IURP FRPSURPLVLQJ WKH SDWLHQW¶V
health upon cost effectiveness. [12, 13] 
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